|
2025
|
Invention
|
Therapeutic application of 64cu-labelled conjugates for site-specific upar-targeting. The present... |
|
2024
|
Invention
|
Urokinase-type plasminogen activator receptor (upar)-pet/ct in brain tumours. The present inventi... |
|
|
P/S
|
Diagnostic reagents for medical purposes for prevention, detection, diagnosis and treatment of ca... |
|
|
P/S
|
Diagnostic preparations for medical purposes |
|
|
P/S
|
Diagnostic preparations for medical purposes Research and development of diagnostic preparations ... |
|
|
Invention
|
Radionuclide labelled peptide conjugate for site-specific upar-targeting. The present invention p... |
|
2022
|
Invention
|
Urokinase-type plasminogen activator receptor (upar)-pet/ct in neuroendocrine neoplams.
The pres... |
|
|
Invention
|
Urokinase-type plasminogen activator receptor (upar)-pet/ct in neuroendocrine neoplams. The prese... |
|
|
Invention
|
Urokinase-type plasminogen activator receptor (upar)-pet/ct in head and neck squamous cell carcin... |
|
|
Invention
|
Positron emitting radionuclide labeled peptides for human upar pet imaging. There is provided a p... |
|
2021
|
Invention
|
Urokinase plasminogen activator receptor targeted radiolabeled peptide conjugates.
The present i... |
|
2020
|
P/S
|
Medical preparations for treating cancer. |
|
|
P/S
|
Medical preparations for treating cancer |
|
2019
|
P/S
|
Diagnostic preparations for medical purposes. |
|
|
P/S
|
Medical preparations for treating cancer. |
|
2017
|
Invention
|
Positron emitting radionuclide labeled peptides for human upar pet imaging.
There is provided a ... |
|
2016
|
P/S
|
Diagnostic preparations for medical purposes. |
|
|
P/S
|
Diagnostic preparations for medical purposes. Research and development of diagnostic preparations... |
